438 related articles for article (PubMed ID: 24429275)
1. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
[TBL] [Abstract][Full Text] [Related]
2. A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD.
Singh D; Martinez FJ; Watz H; Bengtsson T; Maurer BT
Respir Res; 2020 Feb; 21(1):47. PubMed ID: 32041601
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Cass LM; Gunawardena KA; Macmahon MM; Bye A
Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
Grootendorst DC; Gauw SA; Benschop N; Sterk PJ; Hiemstra PS; Rabe KF
Pulm Pharmacol Ther; 2003; 16(6):341-7. PubMed ID: 14580925
[TBL] [Abstract][Full Text] [Related]
5. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
7. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
8. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
[TBL] [Abstract][Full Text] [Related]
10. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies.
Wenzel S; Wilbraham D; Fuller R; Getz EB; Longphre M
Lancet; 2007 Oct; 370(9596):1422-31. PubMed ID: 17950857
[TBL] [Abstract][Full Text] [Related]
11. Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
Rennard SI; Schachter N; Strek M; Rickard K; Amit O
Chest; 2006 Jan; 129(1):56-66. PubMed ID: 16424413
[TBL] [Abstract][Full Text] [Related]
12. A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy.
Ferguson GT; Kerwin EM; Rheault T; Bengtsson T; Rickard K
Int J Chron Obstruct Pulmon Dis; 2021; 16():1137-1148. PubMed ID: 33911859
[TBL] [Abstract][Full Text] [Related]
13. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhaled prostaglandin E2 on allergen-induced asthma.
Pavord ID; Wong CS; Williams J; Tattersfield AE
Am Rev Respir Dis; 1993 Jul; 148(1):87-90. PubMed ID: 8317820
[TBL] [Abstract][Full Text] [Related]
15. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.
Grootendorst DC; Gauw SA; Verhoosel RM; Sterk PJ; Hospers JJ; Bredenbröker D; Bethke TD; Hiemstra PS; Rabe KF
Thorax; 2007 Dec; 62(12):1081-7. PubMed ID: 17573446
[TBL] [Abstract][Full Text] [Related]
16. Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial.
Rabe KF; Bateman ED; O'Donnell D; Witte S; Bredenbröker D; Bethke TD
Lancet; 2005 Aug 13-19; 366(9485):563-71. PubMed ID: 16099292
[TBL] [Abstract][Full Text] [Related]
17. The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation.
Laursen LC; Lindqvist A; Hepburn T; Lloyd J; Perrett J; Sanders N; Rocchiccioli K
Respir Med; 2003 Jan; 97 Suppl A():S23-33. PubMed ID: 12564608
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.
Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
Lancet; 1999 May; 353(9167):1819-23. PubMed ID: 10359405
[TBL] [Abstract][Full Text] [Related]
19. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).
Angus RM; Millar EA; Chalmers GW; Thomson NC
Thorax; 1996 Jan; 51(1):71-4. PubMed ID: 8658373
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma.
Taube C; Kanniess F; Grönke L; Richter K; Mücke M; Paasch K; Eichler G; Jörres RA; Magnussen H
Respir Med; 2003 May; 97(5):568-77. PubMed ID: 12735677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
